Curcumin Modulates α-Synuclein Aggregation and Toxicity

Citations Over TimeTop 10% of 2012 papers

Abstract

In human beings, Parkinson's disease (PD) is associated with the oligomerization and amyloid formation of α-synuclein (α-Syn). The polyphenolic Asian food ingredient curcumin has proven to be effective against a wide range of human diseases including cancers and neurological disorders. While curcumin has been shown to significantly reduce cell toxicity of α-Syn aggregates, its mechanism of action remains unexplored. Here, using a series of biophysical techniques, we demonstrate that curcumin reduces toxicity by binding to preformed oligomers and fibrils and altering their hydrophobic surface exposure. Further, our fluorescence and two-dimensional nuclear magnetic resonance (2D-NMR) data indicate that curcumin does not bind to monomeric α-Syn but binds specifically to oligomeric intermediates. The degree of curcumin binding correlates with the extent of α-Syn oligomerization, suggesting that the ordered structure of protein is required for effective curcumin binding. The acceleration of aggregation by curcumin may decrease the population of toxic oligomeric intermediates of α-Syn. Collectively; our results suggest that curcumin and related polyphenolic compounds can be pursued as candidate drug targets for treatment of PD and other neurological diseases.

Related Papers

• → Curcumin and Curcumin-like Molecules: From Spice to Drugs(2013)188 cited
• → Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives(2013)24 cited
• Anti Oxidant Potential of “Cureit”- A Novel BioAvailable Curcumin Formulation(2014)
• → Metabolic Fate of Curcumin in the Gastrointestinal Tract in Mice(2016)1 cited
• → Evaluation of Curcumin Nanoparticles against Rabbit Skin Infection(2023)